European respiratory journal, 58(3):2003492. European Respiratory Society Heyckendorf, Jan; Marwitz, Sebastian; Reimann, Maja; Avsar, Korkut; DiNardo, Andrew; Günther, Gunar; Hoelscher, Michael; Ibraim, Elmira; Kalsdorf, Barbara; Kaufmann, Stefan H E; Kontsevaya, Irina; van Leth, Frank; Mandalakas, Anna Maria; Maurer, Florian P; Müller, Marius; Nitschkowski, Dörte; Olaru, Ioana D; Popa, Cristina; Rachow, Andrea; Rolling, Thierry; ... (2021). Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model. European respiratory journal, 58(3) European Respiratory Society 10.1183/13993003.03492-2020 European Respiratory Journal, 58(3):2003492, 1-13. European Respiratory Society Heyckendorf, J, Marwitz, S, Reimann, M, Avsar, K, DiNardo, A R, Günther, G, Hoelscher, M, Ibraim, E, Kalsdorf, B, Kaufmann, S H E, Kontsevaya, I, van Leth, F, Mandalakas, A M, Maurer, F P, Müller, M, Nitschkowski, D, Olaru, I D, Popa, C, Rachow, A, Rolling, T, Rybniker, J, Salzer, H J F, Sanchez-Carballo, P, Schuhmann, M, Schaub, D, Spinu, V, Suárez, I, Terhalle, E, Unnewehr, M, Weiner, J, Goldmann, T & Lange, C 2021, ' Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model ', European Respiratory Journal, vol. 58, no. 3, 2003492, pp. 1-13 . https://doi.org/10.1183/13993003.03492-2020
The Lancet Infectious Diseases, 21(8). Lancet Publishing Group DZIF-TB cohort study group 2021, ' Pathogen-free diagnosis of tuberculosis ', The Lancet Infectious Diseases, vol. 21, no. 8, pp. 1066 . https://doi.org/10.1016/S1473-3099(21)00337-6